1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A genome-wide association study of social trust in 33,882 Danish blood donors
(
- Contribution to journal › Article
-
Mark
Human Genetic Variation at rs10071329 Correlates with Adiposity-related Traits, Modulates PPARGC1B Expression, and Alters Brown Adipocyte Function
2024) In Diabetes(
- Contribution to journal › Article
- 2023
-
Mark
A phenome-wide comparative analysis of genetic discordance between obesity and type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover
(
- Contribution to journal › Article
-
Mark
Reduced Expression Level of Protein Phosphatase PPM1E Serves to Maintain Insulin Secretion in Type 2 Diabetes
(
- Contribution to journal › Article
-
Mark
Identification of a weight loss-associated causal eQTL in MTIF3 and the effects of MTIF3 deficiency on human adipocyte function
2023) In eLife(
- Contribution to journal › Article
- 2022
-
Mark
Genomic editing of metformin efficacy-associated genetic variants in SLC47A1 does not alter SLC47A1 expression
(
- Contribution to journal › Article
- 2021
-
Mark
CRISPR editing of the PPARGC1A Gly482ser (rs8192678) polymorphism in human white adipose cells shows differential effects on mitochondrial function and adipogenesis.
2021) European Association for the Study of Diabetes (EASD) 57th Annual meeting In Diabetologia 64(Suppl 1). p.159-159(
- Contribution to journal › Published meeting abstract
-
Mark
Genetic variation at RAB3GAP2 and its role in exercise-related adaptation and recovery
2021) p.1-16(
- Working paper/Preprint › Preprint in preprint archive
- 2020
-
Mark
Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes
(
- Contribution to journal › Article